Insider Buy/Sell Details for the Healthcare Sector — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2173)
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
104,091
Price
$107.96
Total Value
$11.24M
Shares Held After
87,102
% of Holdings
54.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
800
Price
$110.76
Total Value
$88.61K
Shares Held After
191,292
% of Holdings
0.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,536
Price
$110.02
Total Value
$279.01K
Shares Held After
192,092
% of Holdings
1.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,373
Price
$109.10
Total Value
$258.89K
Shares Held After
194,628
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
23,907
Price
$108.05
Total Value
$2.58M
Shares Held After
197,001
% of Holdings
10.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
10,384
Price
$107.49
Total Value
$1.12M
Shares Held After
220,908
% of Holdings
4.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
10,000
Price
$7.48
Total Value
$74.76K
Shares Held After
590,887
% of Holdings
1.7%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
7,000
Price
$7.02
Total Value
$49.15K
Shares Held After
600,887
% of Holdings
1.2%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
50,000
Price
$0.03
Total Value
$1.50K
Shares Held After
30,049,930
% of Holdings
0.2%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
5,222
Price
$11.40
Total Value
$59.53K
Shares Held After
1,543,518
% of Holdings
0.3%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
300
Price
$131.02
Total Value
$39.31K
Shares Held After
155,487
% of Holdings
0.2%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
4,945
Price
$130.23
Total Value
$643.99K
Shares Held After
155,787
% of Holdings
3.1%
Merck&Co., Inc. (MRK)
DeLuca Richard R. — EVP&Pres, Merck Animal Heallth
Shares
805
Price
$131.02
Total Value
$105.47K
Shares Held After
160,732
% of Holdings
0.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
20,840
Price
$26.06
Total Value
$543.09K
Shares Held After
87,664
% of Holdings
19.2%
Bausch&Lomb Corp (BLCO)
VON ESCHENBACH ANDREW C. — Director
Shares
12,500
Price
$16.50
Total Value
$206.25K
Shares Held After
69,792
% of Holdings
15.2%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
10,494
Price
$7.00
Total Value
$73.46K
Shares Held After
2,836,098
% of Holdings
0.4%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
10,494
Price
$7.00
Total Value
$73.46K
Shares Held After
2,836,098
% of Holdings
0.4%
TENET HEALTHCARE CORP (THC)
Romo Tammy — Director
Shares
4,922
Price
$264.15
Total Value
$1.30M
Shares Held After
30,784
% of Holdings
13.8%
AdaptHealth Corp. (AHCO)
SAMET KENNETH A — Director
Shares
23,500
Price
$6.38
Total Value
$149.93K
Shares Held After
48,569
% of Holdings
48.4%
AdaptHealth Corp. (AHCO)
WOLF DALE B — Director
Shares
20,000
Price
$6.37
Total Value
$127.40K
Shares Held After
143,234
% of Holdings
14.0%
UFP TECHNOLOGIES INC (UFPT)
BAILLY R JEFFREY — Director
Shares
2,805
Price
$320.05
Total Value
$897.74K
Shares Held After
18,024
% of Holdings
13.5%
UFP TECHNOLOGIES INC (UFPT)
BAILLY R JEFFREY — Director
Shares
7,877
Price
$318.12
Total Value
$2.51M
Shares Held After
20,829
% of Holdings
27.4%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
736
Price
$258.53
Total Value
$190.28K
Shares Held After
11,852
% of Holdings
5.8%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
1,205
Price
$258.53
Total Value
$311.53K
Shares Held After
12,588
% of Holdings
8.7%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
404
Price
$258.53
Total Value
$104.45K
Shares Held After
13,793
% of Holdings
2.8%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
482
Price
$265.17
Total Value
$127.81K
Shares Held After
11,852
% of Holdings
3.9%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
620
Price
$263.94
Total Value
$163.64K
Shares Held After
12,334
% of Holdings
4.8%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
213
Price
$262.37
Total Value
$55.88K
Shares Held After
12,954
% of Holdings
1.6%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
810
Price
$261.45
Total Value
$211.77K
Shares Held After
13,167
% of Holdings
5.8%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
901
Price
$260.63
Total Value
$234.83K
Shares Held After
13,977
% of Holdings
6.1%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Knell Michael Gunnar — SVP, Finance and CAO
Shares
1,274
Price
$259.07
Total Value
$330.06K
Shares Held After
14,878
% of Holdings
7.9%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Creamer Victoria L — EVP&Chief People Officer
Shares
4,179
Price
$259.16
Total Value
$1.08M
Shares Held After
30,051
% of Holdings
12.2%
Pennant Group, Inc. (PNTG)
Cheney Kirk Sterling — EVP, GC and Corp Secy
Shares
1,393
Price
$38.52
Total Value
$53.66K
Shares Held After
18,401
% of Holdings
7.0%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
4,285
Price
$38.52
Total Value
$165.07K
Shares Held After
99,544
% of Holdings
4.1%
Pennant Group, Inc. (PNTG)
Steik Jason Paul — Chief Clinical Officer
Shares
1,394
Price
$38.52
Total Value
$53.70K
Shares Held After
15,106
% of Holdings
8.4%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
685
Price
$0.22
Total Value
$150.70
Shares Held After
31,979
% of Holdings
2.1%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
174,721
Price
$8.10
Total Value
$1.42M
Shares Held After
5,439,000
% of Holdings
3.1%
AMGEN INC (AMGN)
Grygiel Nancy A. — SVP&CCO
Shares
1,000
Price
$402.16
Total Value
$402.16K
Shares Held After
7,340
% of Holdings
12.0%
AMGEN INC (AMGN)
Grygiel Nancy A. — SVP&CCO
Shares
1,970
Price
$402.16
Total Value
$792.26K
Shares Held After
7,340
% of Holdings
21.2%
AMGEN INC (AMGN)
Miller Derek — SVP, Human Resources
Shares
1,821
Price
$402.54
Total Value
$733.03K
Shares Held After
12,462
% of Holdings
12.7%
AMGEN INC (AMGN)
Miller Derek — SVP, Human Resources
Shares
2,069
Price
$402.54
Total Value
$832.86K
Shares Held After
12,462
% of Holdings
14.2%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
4,660
Price
$213.95
Total Value
$997.01K
Shares Held After
7,229
% of Holdings
39.2%
JOHNSON&JOHNSON (JNJ)
Forminard Elizabeth — EVP, Chief Legal Officer
Shares
6,574
Price
$255.93
Total Value
$1.68M
Shares Held After
16,994
% of Holdings
27.9%
JOHNSON&JOHNSON (JNJ)
Forminard Elizabeth — EVP, Chief Legal Officer
Shares
9,344
Price
$257.75
Total Value
$2.41M
Shares Held After
23,568
% of Holdings
28.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
9,292
Price
$29.34
Total Value
$272.60K
Shares Held After
67,828
% of Holdings
12.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
5,000
Price
$29.00
Total Value
$145.00K
Shares Held After
77,120
% of Holdings
6.1%
WATERS CORP /DE/ (WAT)
KUEBLER CHRISTOPHER A — Director
Shares
3,626
Price
$397.94
Total Value
$1.44M
Shares Held After
17,808
% of Holdings
16.9%
SHOULDER INNOVATIONS, INC. (SI)
Gilde Healthcare Holding B.V. — 10% Owner
Shares
2,095
Price
$22.60
Total Value
$47.35K
Shares Held After
2,212,207
% of Holdings
0.1%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,975
Price
$18.06
Total Value
$1.01M
Shares Held After
204,940
% of Holdings
21.5%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
55,882
Price
$18.17
Total Value
$1.02M
Shares Held After
260,915
% of Holdings
17.6%
2173 transactions